Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response.
BMC Cancer
; 15: 713, 2015 Oct 16.
Article
in En
| MEDLINE
| ID: mdl-26474549
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Antibodies, Monoclonal, Humanized
/
ErbB Receptors
/
Antibodies, Monoclonal
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2015
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Reino Unido